INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,394 Cr | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr |
What is the latest Total Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,394 Cr |
| Mar2024 | ₹1,133 Cr |
| Mar2023 | ₹1,794 Cr |
| Mar2022 | ₹1,749 Cr |
| Mar2021 | ₹1,758 Cr |
How is Total Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,394 Cr | 22.98 | |
| Mar2024 | ₹1,133 Cr | -36.84 | |
| Mar2023 | ₹1,794 Cr | 2.59 | |
| Mar2022 | ₹1,749 Cr | -0.52 | |
| Mar2021 | ₹1,758 Cr | - | |
Compare Total Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,208.7 Cr | 5.8% | 10.5% | 67.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 5.8% |
10.5% |
67.2% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses